Cantor Fitzgerald Lowers Artiva Biotherapeutics (NASDAQ:ARTV) Price Target to $20.00
Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) had its price target cut by Cantor Fitzgerald from $23.00 to $20.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also weighed in on ARTV. Needham & Company LLC reaffirmed a “buy” rating and […]
Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) had its price target cut by Cantor Fitzgerald from $23.00 to $20.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also weighed in on ARTV. Needham & Company LLC reaffirmed a “buy” rating and […]
